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Abstract It has been proposed that the pICln protein forms a
nucleotide-sensitive plasma membrane anion channel with a
GXGXG motif being an essential component of the extracellular
nucleotide-binding site. To evaluate this hypothesis, we have
performed voltage-clamp experiments on Xenopus laevis oocytes
injected with RNA encoding a rat mutant pICln in which the three
glycines of the putative nucleotide-binding site have been changed
into alanines (G54A; G56A; G58A). The injected oocytes
displayed outwardly rectifying anion currents, which were
voltage-dependently blocked by extracellular cAMP, but which
were not affected by removal of extracellular Ca2+. Furthermore,
the mutation did not affect the voltage-dependent inactivation.
We therefore conclude that there is no evidence in favour of an
extracellular nucleotide-binding site in pICln.
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1. Introduction
Anion channels activated by cell swelling have been identi-
¢ed in a large number of mammalian and non-mammalian
cell types [1^3]. These volume-regulated anion channels
(VRACs) allow the e¥ux of Cl3 and organic osmolytes and
thereby contribute to regulatory volume decrease [3]. Over the
past years, several papers have appeared in which VRAC has
been directly linked with the protein pICln [4^6]. This protein
was originally identi¢ed as a nucleotide-sensitive Cl3 channel
due to its ability to induce a Cl3 current after its expression in
Xenopus oocytes [7]. This current, also termed ICln, has the
following characteristics: outward recti¢cation; block by ex-
tracellular nucleotides; slow inactivation at positive poten-
tials ; independent of extracellular Ca2 [7]. Phenotypic simi-
larities between ICln and ICl;swell as well as the ¢nding that
ICl;swell in NIH/3T3 ¢broblast was reduced after treatment
with antisense pICln oligonucleotides led Paulmichl and co-
workers to conclude that pICln corresponds to VRAC [5^7].
In contrast, Clapham and co-workers [4,8] proposed that pICln
is not VRAC itself but rather a critical cytosolic regulator of
VRAC. Two lines of evidence supported this latter hypothesis.
Firstly, Xenopus oocytes express pICln endogenously and this
protein is located in the cytosol. Secondly, Xenopus oocytes
have an endogenous ICl;swell, proposed to be identical to ICln
(but see [9]), which was inhibited by injecting a monoclonal
antibody against pICln.
An apparently conclusive experiment in favour of pICln
being an anion channel originated from the originally pro-
posed structural model of pICln. A GXGXG sequence (amino
acids 49^53 in MDCK pICln) was predicted to lie at the ex-
tracellular side and to form a ‘consensus’ nucleotide-binding
site responsible for the block of ICln by extracellular nucleo-
tides [7]. Experimental support for this contention was drawn
from experiments in which a mutant MDCK pICln (G49A/
G51A/G53A) was expressed in Xenopus oocytes. Currents ob-
served after expression of the mutant protein di¡ered in three
aspects from wild-type ICln : IClnÿmut was nucleotide-insensi-
tive, Ca2-dependent and it activated slowly at positive po-
tentials [7].
The mutagenesis data seemed to provide conclusive evi-
dence for a channel function (see also [10,11]), but subsequent
observations (cytosolic location; ICln being an endogenous
Xenopus current) have questioned the channel model for
pICln [4,9,12]. In view of the ongoing controversy, we have
repeated these crucial experiments by expressing mutant rat
pICln in Xenopus oocytes.
2. Materials and methods
Stage V^VI Xenopus laevis oocytes were isolated by partial ovariec-
tomy under anaesthesia (Tricaine, 1 g/l). Anaesthetised animals were
then kept on ice during dissection. The oocytes were defolliculated by
treatment with 2 mg/ml collagenase in zero calcium ND-96 solution
(see below). A cDNA clone encoding rat mutant pICln (G54A/G56A/
G58A) was obtained from K. Strange (Vanderbilt University Medical
Center, Nashville, TN, USA). RNA transcription and puri¢cation
were performed as described previously [9]. Oocytes were injected
with 50 nl of 10^100 ng/Wl of the rat mutant pICln RNA. Oocytes
were then incubated at 18‡C for 2 or 3 days in ND-96 solution sup-
plemented with gentamicin sulphate (50 mg/ml). The ND-96 solution
contained (in mM): 96 NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES,
pH 7.5 (210 þ 5 mOsm/kg). Expression of mutant pICln was veri¢ed by
Western blot analysis using a polyclonal anti-pICln antiserum as de-
scribed previously [13]. Whole-cell currents from oocytes were re-
corded using the two-microelectrode voltage-clamp technique by
means of a home-made ampli¢er. Voltage and current electrodes
were pulled from borosilicate glass and had DC resistances between
0.5 and 2 M6 when ¢lled with 3 M KCl. Current records were ¢ltered
using a four-pole low-pass Bessel ¢lter. To eliminate the e¡ect of
voltage drop across the bath-grounding electrode, the bath potential
was actively controlled. Experiments were performed at room temper-
ature (V25‡C). The standard bath solution during two-microelec-
trode voltage-clamp experiments was ND-96, which, when indicated,
was supplemented with 1 mM cAMP (Sigma) or with 1 mM EGTA.
In the latter case, CaCl2 was omitted from the solution.
3. Results
Xenopus oocytes were injected with RNA encoding rat mu-
tant pICln (G54A; G56A; G58A). This mutation is equivalent
to the G49A/G51A/G53A mutation in MDCK pICln tested by
Paulmichl et al. [7]. Two control experiments were performed
to verify expression of the mutant protein. First, the mutant
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pICln cDNA clone was sequenced to con¢rm the introduction
of the triple mutation (data not shown). Second, we per-
formed Western blot analysis of lysates prepared from in-
jected and non-injected Xenopus oocytes using a polyclonal
anti-pICln antiserum [13]. Fig. 1 shows that the anti-pICln anti-
serum detected a 39-kDa protein in injected oocytes, but not
in control oocytes. The 41-kDa band present in both lanes
corresponds to the endogenous Xenopus pICln, which migrates
more slowly than mammalian pICln [13]. Current traces in
response to a voltage-step protocol for both non-injected
and mutant pICln-injected oocytes are displayed in Fig. 2A.
While non-injected oocytes had current amplitudes 6 1 WA at
+100 mV (n = 18), 17 out of 25 oocytes (68%) injected with
mutant pICln mRNA displayed an outwardly rectifying Cl3
current, which inactivated slowly at positive potentials. This
current amounted to 6.4 þ 0.6 WA at +100 mV and 0.8 þ 0.1
WA at 3100 mV (Fig. 2B). Furthermore, it was sensitive to
NPPB (87 þ 8% block with 100 WM at +80 mV) and had an
NO33 s I
3sBr3sCl3s gluconate permeability sequence
(data not shown).
The current in mutant pICln expressing oocytes was blocked
by cAMP (1 mM) in a voltage-dependent manner (Fig. 3A,B).
Removal of extracellular Ca2 and addition of 1 mM EGTA
did not a¡ect outward currents, but activated a small inward
current (Fig. 3C,D). This inward current presumably re£ects
the Ca2-inactivated anion current, which has been described
in Xenopus oocytes [14,15].
4. Discussion
We have shown that expression of the mutant rat pICln
induces an anion current in Xenopus oocytes. The properties
of this current (outward recti¢cation, inactivation at positive
potentials, NO33 s I
3sBr3sCl3Egluconate permeability
sequence and block by NPPB) are identical to those of ICln,
the current which is induced by wild-type pICln. Importantly,
the triple mutation in the putative extracellular nucleotide-
FEBS 20101 17-4-98
Fig. 1. Western blot analysis of protein extracts from control oo-
cytes and oocytes injected with rat mutant pICln (G49A/G51A/
G53A) RNA.
Fig. 2. Macroscopic currents in Xenopus laevis oocytes. Oocytes
were held at 320 mV and stepped for 800 ms to potentials ranging
from 3100 to +100 mV. A: Current traces recorded from a non-in-
jected (left) and a RNA-injected (right) oocyte. B: Average current-
voltage relations for non-injected (a ; n = 18) and RNA-injected (b ;
n = 17) oocytes, measured from step protocols as shown in A.
Fig. 3. E¡ect of cAMP and zero Ca2 on the currents in oocytes in-
jected with mutant pICln (G49A/G51A/G53A) RNA. A: Current-
voltage relations, obtained from linear voltage ramps from 3100 to
+100 mV (0.4 V/s), in the absence and presence of extracellular
cAMP (1 mM). B: E¡ect of 1 mM cAMP on the current measured
at þ 80 mV (n = 6). C: Current-voltage relation in the presence and
absence of extracellular Ca2. D: E¡ect of removal of extracellular
Ca2 on the current measured at þ 80 mV (n = 6). *P6 0.05 (Stu-
dent’s paired t-test).
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binding site of pICln did not a¡ect the nucleotide sensitivity,
Ca2 dependence or kinetics of the expressed current in Xen-
opus oocytes. This is in contrast with the original data of
Paulmichl et al. [7], where the same mutation had dramatic
e¡ects on the kinetics, nucleotide sensitivity and Ca2 depend-
ence of the expressed current. These results, together with the
¢nding that pICln is mainly located in the cytosol [4,12], do
not support the hypothesis that pICln forms a plasma mem-
brane anion channel.
The simplest explanation of our data is that ICln is an en-
dogenous current in Xenopus oocytes, whose expression is
upregulated after expression of certain exogenous proteins.
Indeed, ICln is also present in a small percentage (V5%) of
non-injected or H2O-injected oocytes [7,12]. Additionally, ex-
pression of mutant pICln and of the unrelated protein ClC-6
also induces an anion current identical to ICln [12]. The mu-
tant ICln phenotype reported by Paulmichl et al. [7] is in our
opinion best explained by another endogenous Cl3 current,
namely the slowly activating, nucleotide-insensitive, Ca2-de-
pendent anion current, ICl;Ca. Indeed, the kinetics, the Ca2
dependence and the nucleotide insensitivity of IClnÿmut are
very similar if not identical to those of ICl;Ca (for a discussion,
see [12]).
Recently, we have provided evidence against the hypothesis
that pICln is a critical cytosolic regulator of VRAC. This reg-
ulator hypothesis was based on the contention that the pICln-
induced current in Xenopus oocytes is identical to the endog-
enous swelling-activated anion current ICl;swell. However, we
could show that both currents can be clearly discriminated by
biological, biophysical and pharmacological criteria [9]. We
therefore conclude that there is no evidence in favour of an
extracellular nucleotide-binding site in pICln and, more gener-
ally, that any convincing evidence for a tight link between
pICln and VRAC is currently missing.
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